These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Induction of high-mobility group Box-1 in vitro and in vivo by respiratory syncytial virus. Manti S; Harford TJ; Salpietro C; Rezaee F; Piedimonte G Pediatr Res; 2018 May; 83(5):1049-1056. PubMed ID: 29329282 [TBL] [Abstract][Full Text] [Related]
6. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge. Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats. Kamphuis T; Shafique M; Meijerhof T; Stegmann T; Wilschut J; de Haan A Vaccine; 2013 Apr; 31(17):2169-76. PubMed ID: 23499594 [TBL] [Abstract][Full Text] [Related]
8. Activation of interferon response through toll-like receptor 3 impacts viral pathogenesis and pulmonary toll-like receptor expression during respiratory syncytial virus and influenza infections in the cotton rat Sigmodon hispidus model. Boukhvalova MS; Sotomayor TB; Point RC; Pletneva LM; Prince GA; Blanco JC J Interferon Cytokine Res; 2010 Apr; 30(4):229-42. PubMed ID: 20038196 [TBL] [Abstract][Full Text] [Related]
10. Systemic release of high mobility group box 1 protein during severe murine influenza. Alleva LM; Budd AC; Clark IA J Immunol; 2008 Jul; 181(2):1454-9. PubMed ID: 18606700 [TBL] [Abstract][Full Text] [Related]
11. Acute and Chronic Airway Disease After Human Respiratory Syncytial Virus Infection in Cotton Rats (Sigmodon hispidus). Grieves JL; Yin Z; Durbin RK; Durbin JE Comp Med; 2015 Aug; 65(4):315-26. PubMed ID: 26310461 [TBL] [Abstract][Full Text] [Related]
12. Inflammation and emphysema in cigarette smoke-exposed mice when instilled with poly (I:C) or infected with influenza A or respiratory syncytial viruses. Mebratu YA; Smith KR; Agga GE; Tesfaigzi Y Respir Res; 2016 Jul; 17(1):75. PubMed ID: 27363862 [TBL] [Abstract][Full Text] [Related]
13. van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038 [TBL] [Abstract][Full Text] [Related]
14. Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease. Hwang HS; Lee YT; Kim KH; Park S; Kwon YM; Lee Y; Ko EJ; Jung YJ; Lee JS; Kim YJ; Lee YN; Kim MC; Cho M; Kang SM Virology; 2016 Jul; 494():215-24. PubMed ID: 27123586 [TBL] [Abstract][Full Text] [Related]
15. Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant. Schneider-Ohrum K; Cayatte C; Bennett AS; Rajani GM; McTamney P; Nacel K; Hostetler L; Cheng L; Ren K; O'Day T; Prince GA; McCarthy MP J Virol; 2017 Apr; 91(8):. PubMed ID: 28148790 [TBL] [Abstract][Full Text] [Related]
16. Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines. Fuentes S; Arenas D; Moore MM; Golding H; Khurana S Vaccine; 2017 Jan; 35(4):694-702. PubMed ID: 27989627 [TBL] [Abstract][Full Text] [Related]
17. IL-17A is a common and critical driver of impaired lung function and immunopathology induced by influenza virus, rhinovirus and respiratory syncytial virus. Liu X; Nguyen TH; Sokulsky L; Li X; Garcia Netto K; Hsu AC; Liu C; Laurie K; Barr I; Tay H; Eyers F; Foster PS; Yang M Respirology; 2021 Nov; 26(11):1049-1059. PubMed ID: 34472161 [TBL] [Abstract][Full Text] [Related]
18. Anti-high mobility group box-1 monoclonal antibody treatment provides protection against influenza A virus (H1N1)-induced pneumonia in mice. Nosaka N; Yashiro M; Yamada M; Fujii Y; Tsukahara H; Liu K; Nishibori M; Matsukawa A; Morishima T Crit Care; 2015 Jun; 19(1):249. PubMed ID: 26067826 [TBL] [Abstract][Full Text] [Related]
19. High-mobility group box-1 protein from CC10 Chen S; Yu G; Xie J; Tang W; Gao L; Long X; Ren L; Xie X; Deng Y; Fu Z; Liu E Am J Physiol Lung Cell Mol Physiol; 2019 Jan; 316(1):L280-L290. PubMed ID: 30407867 [TBL] [Abstract][Full Text] [Related]
20. Anti-high mobility group box-1 monoclonal antibody treatment of brain edema induced by influenza infection and lipopolysaccharide. Nosaka N; Hatayama K; Yamada M; Fujii Y; Yashiro M; Wake H; Tsukahara H; Nishibori M; Morishima T J Med Virol; 2018 Jul; 90(7):1192-1198. PubMed ID: 29573352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]